OAR 845-025-7190: Effective Date

(1) These rules become effective on August 15, 2018. On and after August 15, 2018, all package and label applications received by the Commission will be reviewed and evaluated under these rules. (2) All marijuana items and hemp items packaged or transferred for sale to a consumer on or after April 1, 2019 must be labeled and packaged according to these rules. (3) On and after January 1, 2020, marijuana items and hemp items with labels approved prior to August 15, 2018, can no longer be sold, offered for sale, or transferred to a consumer, patient, or designated primary caregiver. (4) For inhalable cannabinoid products that contain a non-cannabis additive and are processed or manufactured on or after April 1, 2021, all labels must be pre-approved by the Commission in accordance with these rules. (a) An inhalable cannabinoid product with a label approved by the Commission prior to April 1, 2021, that contains a non-cannabis additive and that does not meet the requirements of OAR 845-025-3265 or 845-025-7120 may not be possessed, sold, delivered, transferred, transported, purchased, or received on or after July 1, 2021. (b) An inhalable cannabinoid product that contains a non-cannabis additive that is manufactured prior to April 1, 2021 may be possessed, sold, delivered, transferred, transported, purchased, or received prior to July 1, 2021. (5) A marijuana item or hemp item that contains an artificially derived cannabinoid allowed by OAR 845-025-1310 and is sold or transferred on or after July 1, 2022, must have a label that has been pre-approved by the Commission in accordance with these rules.